1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RAB11FIP3 CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA ACAA2 CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA ZYG11B CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA CSTF1 CTRPv2 pan-cancer AAC -0.13 5e-05
mRNA MYT1L CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA HNRNPD CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA HAUS1 CTRPv2 pan-cancer AAC 0.13 5e-05
mRNA ATP6V1E1 CTRPv2 pan-cancer AAC -0.14 5e-05
mRNA GALE CTRPv2 pan-cancer AAC -0.14 5e-05
mRNA ZNF24 CTRPv2 pan-cancer AAC 0.14 5e-05
Download CSV